To examine the effect of silencing KRAS in HER2-positive gastric cancer cell lines, we performed a cell viability assay and Western blotting after the transfection of MKN-7 and KATO-III cells with siR-KRAS. The gene discussed is ERBB2; the disease is gastric cancer.